Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Angiopathy

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    63 result(s) found for: Angiopathy. Displaying page 1 of 4.
    1  2  3  4  Next»
    EudraCT Number: 2018-002548-10 Sponsor Protocol Number: CAAAMY Start Date*: 2019-10-10
    Sponsor Name:OSPEDALE SAN RAFFAELE
    Full Title: PET/MRI study of amyloid burden in patients with Cerebral Amyloid Angiopathy-related inflammation
    Medical condition: cerebral amyloid angiopathy related inflammation (CAA-ri)
    Disease: Version SOC Term Classification Code Term Level
    21.1 10029205 - Nervous system disorders 10068044 Cerebral amyloid angiopathy PT
    21.1 10029205 - Nervous system disorders 10068044 Cerebral amyloid angiopathy PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-001557-27 Sponsor Protocol Number: A9951024 Start Date*: 2014-01-13
    Sponsor Name:Pfizer Inc. 235 East 42nd Street, New York, NY 10017
    Full Title: A PHASE 2, RANDOMIZED, DOUBLE BLIND PLACEBO CONTROLLED TRIALTO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND EFFICACY OF PF-04360365 (PONEZUMAB) IN ADULT SUBJECTS WITH PROBABLE CEREBRAL A...
    Medical condition: Cerebral Amyloid Angiopathy (CAA)
    Disease: Version SOC Term Classification Code Term Level
    17.1 10029205 - Nervous system disorders 10068044 Cerebral amyloid angiopathy PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2005-002072-15 Sponsor Protocol Number: NACARGSCINTI Start Date*: 2005-07-01
    Sponsor Name:AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO"
    Full Title: EFFECTS OF TREATMENT WITH L-ARGININE ASSOCIATED TO N-ACETILCYSTEINE IN PATIENTS WITH CORONARY ISCHEMIC CARDIOPATHY EVALUATED WITH MYOCARDIAL SPECT (TC99) WITH EXERCISE
    Medical condition: TO IMPROVE CORONARY PERFUSION INCREASING THE PRODUCTION OF NITRIC OXIDE IN CORONAROPATHIC DIABETIC SUBJECTS BY MEANS OF ARGININE AND ACETYLCYSTEINE ADMINISTRATION
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061815 PT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2011-005111-91 Sponsor Protocol Number: RBHP2011LUSSON Start Date*: 2012-01-19
    Sponsor Name:CHU de Clermont-Ferrand
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.1 10047065 - Vascular disorders 10034633 Peripheral vascular disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-004641-29 Sponsor Protocol Number: VAS07BE Start Date*: 2008-10-21
    Sponsor Name:VAS VASCULAR INDEPENDENT RESEACH AND EDUCATION EUROPEAN ORGANIZATION. C/O UNIV MILANO. OSP. L. SACCO
    Full Title: Non profit study of phase II randomized, double blind, placebo controlled, parallel groups, dose-finding trial with 3 different doses of Betaine versus placebo in subjects affected by PAD (Peripher...
    Medical condition: Leriche-Fontaine stage II PAD presenting symptoms of intermittent claudication
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013283 Disorder vascular peripheral LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended) SI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-005612-40 Sponsor Protocol Number: DAM/001/08 Start Date*: 2008-11-27
    Sponsor Name:FARMACEUTICI DAMOR
    Full Title: Open-label, controlled, randomised, multicentre, parallel group clinical trial of efficacy and tolerability of heparan sulfate slow-release 120 mg tablets and defibrotide 400 mg capsules in the tre...
    Medical condition: Patients with chronic venous insufficiency
    Disease: Version SOC Term Classification Code Term Level
    9.1 10013283 Disorder vascular peripheral LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005399-42 Sponsor Protocol Number: GJ001 Start Date*: 2007-04-11
    Sponsor Name:Guy's & St Thomas' NHS Foundation Trust
    Full Title: Improving symptoms of intermittent claudication in patients with erectile dysfunction and peripheral vascular disease: a pilot study assessing the benefit of daily dosing with tadalafil (Cialis) 10...
    Medical condition: Peripheral vascular disease (PVD)
    Disease: Version SOC Term Classification Code Term Level
    14.0 10047065 - Vascular disorders 10034634 Peripheral vascular disease NOS LLT
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2007-003376-20 Sponsor Protocol Number: 709/07 Start Date*: 2008-09-23
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: ANTITHROMBOTIC THERAPY IN THE DIABETIC PATIENT: STUDY ON THE EFFECT ON PLATELET FUNCTIONALITY OF A GREATER DOSAGE OF ASPIRIN OR THE ASSOCIATION OF LOW DOSES OF ASPIRIN PLUS SELECTIVE INHIBITOR OF ...
    Medical condition: PRIMARY PREVENTION ON MELLITUS DIABETES NIDDM
    Disease: Version SOC Term Classification Code Term Level
    6.1 10061815 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-005759-21 Sponsor Protocol Number: Start Date*: 2011-04-21
    Sponsor Name:University of Oxford
    Full Title: Can atorvastatin improve vascular function in women with a history preeclampsia? A Randomised, double-blinded, placebo-controlled crossover trial of atorvastatin in women with a history of preeclam...
    Medical condition: Cardiovascular disease in women with a history of preeclampsia
    Disease: Version SOC Term Classification Code Term Level
    13.1 10047065 - Vascular disorders 10047063 Vascular disorder peripheral LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-005006-39 Sponsor Protocol Number: selene 2008 Start Date*: 2009-02-24
    Sponsor Name:AZIENDA OSPEDALIERA PISANA
    Full Title: Study on the vascular effects of ACE-I + CA-antagonist (Enalapril + Lercanidipine) versus ACE-I + diuretic (Enalapril + hydrochlorothiazidE) combinations in hypertensive patients with metabolic syn...
    Medical condition: hypertensive patients of either sex aged 40-69 years
    Disease: Version SOC Term Classification Code Term Level
    9.1 10057166 HLGT
    9.1 10047065 SOC
    9.1 10047065 SOC
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-013681-92 Sponsor Protocol Number: PREVENT-ICARUS V1 Start Date*: 2009-10-29
    Sponsor Name:AZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
    Full Title: PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecro...
    Medical condition: Elective coronary angioplasty
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-017640-13 Sponsor Protocol Number: Blocchi09 Start Date*: 2010-04-21
    Sponsor Name:ISTITUTI ORTOPEDICI RIZZOLI
    Full Title: Continuous peripheral block in the pain and ischemic ulcer treatment in arteriopathy patients
    Medical condition: Arteriophaty patients with ischemic pain and/or ulcers
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-006304-38 Sponsor Protocol Number: 1381/08 Start Date*: 2008-12-23
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Protocol for a study on male patients suffering from peripheral arterial disease with severe chronic limb ischemia during treatment with iloprost: assessment of oxidative stress and organic erectil...
    Medical condition: peripheral arterial disease and organic erectile dysfunction.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 Vascular disorders SOC
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2009-017448-15 Sponsor Protocol Number: GAIN Start Date*: 2009-12-15
    Sponsor Name:ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
    Full Title: A multicenter, open label, hystorical Group controlled study by evaluate the effectivness and sAfety in the use of INfliximab (Tumor necrosis factor - alfa antibody) in preventing or reducing cereb...
    Medical condition: patient with cerebral hemorrhage
    Disease: Version SOC Term Classification Code Term Level
    9.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2007-001347-21 Sponsor Protocol Number: EPA 2007 Start Date*: 2007-03-05
    Sponsor Name:OSPEDALE POLICLINICO S. MATTEO
    Full Title: A randomised clinical trial on heparin versus saline solution (NaCl 0,9%) in the maintenance of peripherical venous catheters
    Medical condition: PVC flow maintenance
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-005056-16 Sponsor Protocol Number: ATORV/IMAPERIPROC Start Date*: 2007-10-19
    Sponsor Name:OSPEDALE S. RAFFAELE
    Full Title: Atorvastatin at high dosage before coronary stent surgery: effect on peri-procedure miocardic stroke .
    Medical condition: elective PCI in de novo coronaric lesions
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2006-001660-23 Sponsor Protocol Number: AOCP[1].IIb.Prot.DiSalvo.Mazzone.f Start Date*: 2007-11-12
    Sponsor Name:CENTRO STUDI FADOI
    Full Title: Optimized treatment of patients with severe peripheral arterial disease (Leriche-Fontaine stage IIb), when open or endovascular intervention is possible or not, in terms of measurement of pain free...
    Medical condition: Arteropatia obliterante cronica periferica
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2004-000966-10 Sponsor Protocol Number: 38/2004/U/sper Start Date*: 2004-03-23
    Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
    Full Title: na
    Medical condition: ESSENTIAL HYPERTENSION
    Disease: Version SOC Term Classification Code Term Level
    6.1 10047065 SOC
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000706-37 Sponsor Protocol Number: CLLG783X2201 Start Date*: 2017-11-28
    Sponsor Name:Novartis Pharma AG
    Full Title: A Patient and Investigator-blinded, randomized, placebo controlled study of LLG783 in patients with peripheral artery disease (PAD) and intermittent claudication.
    Medical condition: Peripheral Artery Disease (PAD), Intermittent Claudication
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10022562 Intermittent claudication PT
    20.0 10047065 - Vascular disorders 10034633 Peripheral vascular disease LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2008-000771-17 Sponsor Protocol Number: DM2ATV Start Date*: 2008-05-05
    Sponsor Name:RUNMC
    Full Title: Hyperbilirubinemia, the favourable side effect of atazanavir? Influence of atazanavir treatment on endothelial dysfunction, vascular inflammation and heme oxygenase activity in type 2 diabetes mell...
    Medical condition: Type 2 diabetes mellitus
    Disease: Version SOC Term Classification Code Term Level
    9.1 10053246 Type II diabetes peripheral angiopathy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  4  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun May 11 23:02:16 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA